Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Excessive Basal Insulin Dosage When Following the Accepted Titration Method.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: January 19, 2021
Mean basal insulin dose is 0.2 U/kg/d at near normal glycaemia for type 1 or 2 diabetes on continuous subcutaneous insulin infusion or once-nightly basal insulin.
Journal: Diabetes, obesity & metabolism
Published: May 25, 2020
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
Journal: Diabetes technology & therapeutics
Published: March 11, 2017
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: June 30, 2015
Misled by the Morning "Fasting" Plasma Glucose.
Journal: Journal of diabetes science and technology
Published: May 15, 2015
Can a fixed-ratio combination of insulin degludec and liraglutide help Type 2 diabetes patients to optimize glycemic control across the day?
Journal: Expert review of clinical pharmacology
Published: February 21, 2015
Omitting late-night eating may cause hypoglycemia in "well controlled" basal insulin-treated type 2 diabetes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 06, 2014
Individualizing insulin therapy in the management of type 2 diabetes.
Journal: The American journal of medicine
Published: October 06, 2014
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy.
Journal: Diabetes, obesity & metabolism
Published: August 07, 2014
Reassessment of insulin dosing guidelines in continuous subcutaneous insulin infusion treated type 1 diabetes.
Journal: Current diabetes reports
Published: May 06, 2014
Integrating advances in insulin into clinical practice: Advances In insulin formulations.
Journal: The Journal of family practice
Published: October 02, 2013
Last Updated: 09/26/2026